Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden
Martin, F. Z.; Ahlqvist, V. H.; Madley-Dowd, P. C.; Lundberg, M.; Cohen, J. M.; Furu, K.; Rai, D.; Forbes, H.; Easey, K. E.; Haberg, S. E.; Sharp, G. C.; Magnusson, C.; Magnus, M. C.
Show abstract
ObjectivesTo explore the association between antidepressant use during pregnancy and birth outcomes. DesignCohort study. SettingElectronic health record data. Participants2 528 916 singleton births from the UKs Clinical Practice Research Datalink (1996-2018), Norways Medical Birth Registry (2009-2020), and Swedens Medical Birth Register (2006-2020). Main outcome measuresStillbirth, neonatal death, pre- and post-term delivery, small and large for gestational age, and low Apgar score five minutes post-delivery. ResultsA total of 120 209 (4.8%) deliveries were exposed to maternal antidepressant use during pregnancy. Maternal antidepressant use during pregnancy was associated with increased odds of stillbirth (adjusted pooled OR (aOR) 1.16, 95% CI 1.05 to 1.28), preterm delivery (aOR 1.26, 95% CI 1.23 to 1.30), and Apgar score < 7 at 5 minutes (aOR 1.83, 95% CI 1.75 to 1.91). These findings persisted in the discordant sibling analysis, but with higher uncertainty. The adjusted predicted absolute risk for stillbirth was 0.34% (95% CI 0.33 to 0.35) among the unexposed and 0.40% (95% CI 0.36 to 0.44) in the antidepressant exposed. Restricting to women with depression or anxiety, the association between antidepressant exposure and stillbirth attenuated (aOR 1.07, 95% CI 0.94 to 1.21). Paternal antidepressant use was modestly associated with preterm delivery and low Apgar score. Most antidepressants were associated with preterm delivery (except paroxetine) and Apgar score (except mirtazapine and amitriptyline). ConclusionsMaternal antidepressant use during pregnancy may increase the risk of stillbirth, preterm delivery, and low Apgar score, although the absolute risks remained low. Confounding by severity of indication cannot be ruled out, as the severity of symptoms was not available. The modest association between paternal antidepressant use and both preterm delivery and low Apgar score suggests that residual confounding by familial environment cannot be ruled out.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Maternal pre-pregnancy body mass index and risk of preterm birth: a collaboration using large routine health datasets 94%
- Establishing the causal role of intimate partner violence and abuse on depressive symptoms in young adults: a population-based cohort study 92%
- Assessing the impact of maternal blood pressure during pregnancy on perinatal health: A wide-angled Mendelian randomization study 91%
Similar papers in this journal
- Pregnancy pharmacoepidemiology: How often are key methodological elements reported in publications? 93%
- Medication, Vaccine, and Folic Acid Use Among Pregnant Women in Belgium: Insights from the BELpREG Cohort 92%
- Using quantitative bias analysis to adjust for misclassification of COVID-19 outcomes: An applied example of inhaled corticosteroids and COVID-19 outcomes 89%
Similar papers in this journal
- Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada 93%
- Investigating a possible causal relationship between maternal serum urate concentrations and offspring birthweight: A Mendelian randomization study 91%
- Adverse childhood experiences and lower urinary tract symptoms in adolescence: the mediating effect of inflammation 91%
Similar papers in this journal
- Premenstrual disorders and risk of sick leave and unemployment: a prospective cohort study of 15,857 women in Sweden 93%
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP 93%
- Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study 92%
Similar papers in this journal
- Weighting of risk factors for low birth weight: A linked routine data cohort study in Wales, UK 92%
- Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: A data linkage study 92%
- Assessing and predicting adolescent and early adulthood common mental disorders in the ALSPAC cohort using electronic primary care data 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.